Abstract
Sickle cell disease (SCD) is a hereditary blood disorder affecting millions of people in which red blood cells (RBCs) become sickled and lyse easily driven by polymerization of hemoglobin. Chronically, SCD causes anemia and biventricular dysfunction. GBT440 is an experimental treatment for SCD that prevents hemoglobin polymerization. We hypothesized that 17-month-old Berkeley SCD mice treated with GBT440 would have increased hematocrit (Hct) and better biventricular function compared to vehicle treated SCD mice. Our results demonstrate that 3 weeks of GBT440 treatment eliminated chronic anemia, increased left ventricular ejection fraction (LVEF) and stroke volume index, and improved right ventricular function. Overall, our findings support a therapeutic effect of GBT440 in vivo in a small animal model of SCD. Next steps in investigating mechanisms of improved cardiac function are warranted.
Issue Section:
Technical Briefs
References
1.
Piel
,
F. B.
,
Hay
,
S. I.
,
Gupta
,
S.
,
Weatherall
,
D. J.
, and
Williams
,
T. N.
, 2013
, “
Global Burden of Sickle Cell Anaemia in Children Under Five, 2010-2050: Modeling Based on Demographics, Excess Mortality, and Interventions
,” PLoS Med.
,
10
(7
), p. e1001484
.10.1371/journal.pmed.10014842.
Oksenberg
,
D.
,
Dufu
,
K.
,
Patel
,
M. P.
,
Chuang
,
C.
,
Li
,
Z.
,
Xu
,
Q.
,
Silva-Garcia
,
A.
,
Zhou
,
C.
,
Hutchaleelaha
,
A.
,
Patskovska
,
L.
,
Patskovsky
,
Y.
,
Almo
,
S. C.
,
Sinha
,
U.
,
Metcalf
,
B. W.
, and
Archer
,
D. R.
, 2016
, “
GBT440 Increases Haemoglobin Oxygen Affinity, Reduces Sickling and Prolongs RBC Half-Life in a Murine Model of Sickle Cell Disease
,” Br. J. Haemotol.
,
175
(1
), pp. 141
–153
.10.1111/bjh.142143.
Aworunse
,
O.
, 2017
, “National Trends in the Use and Cost of Hospital Care in the U.S. for Sickle Cell Disease
,” Doctoral dissertation, Texas Medical Center
, Houston, Texas
.https://digitalcommons.library.tmc.edu/dissertations/AAI10275138/4.
Lervolino
,
L. G.
,
Baldin
,
P. E.
,
Picado
,
S. M.
,
Calil
,
K. B.
,
Viel
,
A. A.
, and
Campos
,
L. A.
, 2011
, “
Prevalence of Sickle Cell Disease and Sickle Cell Trait in National Neonatal Screening Studies
,” Rev. Bras. Hematol. Hemoterapia
,
33
(1
), pp. 49
–54
.10.5581/1516-8484.201100155.
Gordeuk
,
V. R.
,
Castro
,
O. L.
, and
Machado
,
R. F.
, 2016
, “
Pathophysiology and Treatment of Pulmonary Hypertension in Sickle Cell Disease
,” Blood
,
127
(7
), pp. 820
–828
.10.1182/blood-2015-08-6185616.
Conran
,
N.
, and
Belcher
,
J. D.
, 2018
, “
Inflammation in Sickle Cell Disease
,” Clin. Hemorheol. Microcirc.
,
68
(2–3
), pp. 263
–299
.10.3233/CH-1890127.
Owusu-Ansah
,
A.
,
Ihunnah
,
C. A.
,
Walker
,
A. L.
, and
Ofori-Acquah
,
S. F.
, 2016
, “
Inflammatory Targets of Therapy in Sickle Cell Disease
,” Transl. Res.
,
167
(1
), pp. 281
–297
.10.1016/j.trsl.2015.07.0018.
Dufu
,
K.
, and
Oksenberg
,
D.
, 2018
, “
GBT440 Reverses Sickling of Sickled Red Blood Cells Under Hypoxic Conditions In Vitro
,” Hematol. Rep.
,
10
(2
), p. 7419
.10.4081/hr.2018.74199.
Lehrer-Graiwer
,
J.
,
Howard
,
J.
,
Hemmaway
,
C. J.
,
Awogbade
,
M.
,
Telfer
,
P.
,
Layton
,
M.
,
Mant
,
T.
,
Dufu
,
K.
,
Hutchaleelaha
,
A.
,
Koller
,
T.
,
Oksenberg
,
D.
,
Patel
,
M.
, and
Ramos
,
E.
, 2015
, “
GBT440, a Potent Anti-Sickling Hemoglobin Modifier Reduces Hemolysis, Improves Anemia and Nearly Eliminates Sickle Cells in Peripheral Blood of Patients With Sickle Cell Disease
,” Blood
,
126
(23
), pp. 542
–542
.10.1182/blood.V126.23.542.54210.
Manci
,
E. A.
,
Hillery
,
C. A.
,
Bodian
,
C. A.
,
Zhang
,
Z. G.
,
Lutty
,
G. A.
, and
Coller
,
B. S.
, 2006
, “
Pathology of Berkeley Sickle Cell Mice: Similarities and Differences With Human Sickle Cell Disease
,” Blood
,
107
(4
), pp. 1651
–1658
.10.1182/blood-2005-07-283911.
Markandeya
,
Y. S.
,
Tsubouchi
,
T.
,
Hacker
,
T. A.
,
Wolff
,
M. R.
,
Belardinelli
,
L.
, and
Balijepalli
,
R. C.
, 2016
, “
Inhibition of Late Sodium Current Attenuates Ionic Arrhythmia Mechanism in Ventricular Myocytes Expressing LaminA-N195K Mutation
,” Heart Rhythm
,
13
(11
), pp. 2228
–2236
.10.1016/j.hrthm.2016.08.00712.
The Jackson Laboratory
, 2020
, “Aged C57BL/6J Mice
” The Jackson Laboratory
, Bar Harbor, ME
, accessed Apr. 9, 2020, https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/most-popular-jax-mice-strains/aged-b613.
Dahiya
,
A.
,
Vollbon
,
W.
,
Jellis
,
C.
,
Prior
,
D.
,
Wahi
,
S.
, and
Marwick
,
T.
, 2010
, “
Echocardiographic Assessment of Raised Pulmonary Vascular Resistance: Application to Diagnosis and Follow-Up of Pulmonary Hypertension
,” Heart
,
96
(24
), pp. 2005
–2009
.10.1136/hrt.2010.20483414.
Koestenberger
,
M.
,
Avian
,
A.
,
Grangl
,
G.
,
Burmas
,
A.
,
Kurath-Koller
,
S.
, and
Hansmann
,
G.
, 2016
, “
Right Ventricular Outflow Tract Velocity Time Integral (RVOT VTI) and Tricuspid Regurgitation Velocity/RVOT VTI Ratio in Pediatric Pulmonary Hypertension
,” Int. J. Cardiol.
,
212
, pp. 274
–276
.10.1016/j.ijcard.2016.03.11115.
Schreier
,
D. A.
,
Hacker
,
T. A.
,
Hunter
,
K.
,
Eickoff
,
J.
,
Liu
,
A.
,
Song
,
G.
, and
Chesler
,
N.
, 2014
, “
Impact of Increased Hematocrit on Right Ventricular Afterload in Response to Chronic Hypoxia
,” J. Appl. Physiol.
,
117
(8
), pp. 833
–839
.10.1152/japplphysiol.00059.2014Copyright © 2021 by ASME
You do not currently have access to this content.
